MISP: "Real world evidence of the impact of access, increase knowledge and counseling about the etonogestrel-releasing implant (Implanon NXT®) and the effect upon pregnancy rate, reasons and rates for discontinuation and continuation rate up to two years after insertion in a Brazilian clinic when compared to short acting reversible contraceptives (SHARC)."

Financiamento: Schering-Plough Industria Farmacêutica Ltda.

Pesquisador: Dr. Luis Bahamondes

Linha de Pesquisa: Contracepção, Saúde Sexual e Reprodutiva, Imigrantes

 

 

 

 

 

 

Pesquisa Associada:

To provide a wide comprehension of the MISP implementation status, mechanisms, and objectives (types and delivery modes) among Venezuelan migrants in Roraima State, Brazil  –  Phase 1 e 2

FinanciamentoWHO – World Health Organization

Pesquisador: Dr. Luis Bahamondes